A Multicenter,Investigator-blinded,Randomized, Comparative Study to Evaluate the Efficacy and Safety of Oral NXL103 Versus Oral Linezolid in the Treatment of Complicated Skin and Skin Structure Infections (cSSSI).

Trial Profile

A Multicenter,Investigator-blinded,Randomized, Comparative Study to Evaluate the Efficacy and Safety of Oral NXL103 Versus Oral Linezolid in the Treatment of Complicated Skin and Skin Structure Infections (cSSSI).

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Sep 2015

At a glance

  • Drugs Linopristin/flopristin (Primary) ; Linezolid
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Sponsors Novexel
  • Most Recent Events

    • 07 Nov 2009 Additional location (Guatemala and USA) identified as reported by ClinicalTrials.gov.
    • 06 Nov 2009 Status changed from not yet recruiting to recruiting, according to a Novexel media release.
    • 08 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top